Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Creative Medical Technology Holdings, Inc. before investing.

In this article, we go over a few key elements for understanding Creative Medical Technology Holdings, Inc.’s stock price such as:

• Creative Medical Technology Holdings, Inc.’s current stock price and volume
• Why Creative Medical Technology Holdings, Inc.’s stock price changed recently
• Upgrades and downgrades for CELZ from analysts
• CELZ’s stock price momentum as measured by its relative strength

About Creative Medical Technology Holdings, Inc. (CELZ)

Before we jump into Creative Medical Technology Holdings, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, which is in IND-enabling phase, to treat infertility as a result of premature ovarian failure; iPSCelz, which is in pre-clinical stage, a platform to make cell type in the body; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson’s disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Want to learn more about Creative Medical Technology Holdings, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Creative Medical Technology Holdings, Inc..

Creative Medical Technology Holdings, Inc.’s Stock Price as of Market Close

As of May 05, 2025, 12:29 PM, CST, Creative Medical Technology Holdings, Inc.’s stock price was $2.052.

Creative Medical Technology Holdings, Inc. is up 2.58% from its previous closing price of $2.000.

During the last market session, Creative Medical Technology Holdings, Inc.’s stock traded between $2.000 and $2.120. Currently, there are approximately 1.70 million shares outstanding for Creative Medical Technology Holdings, Inc..

Creative Medical Technology Holdings, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Creative Medical Technology Holdings, Inc. Stock Price History

Creative Medical Technology Holdings, Inc.’s (CELZ) price is currently down 0.89% so far this month.

During the month of May, Creative Medical Technology Holdings, Inc.’s stock price has reached a high of $2.120 and a low of $1.950.

Over the last year, Creative Medical Technology Holdings, Inc. has hit prices as high as $6.900 and as low as $1.690. Year to date, Creative Medical Technology Holdings, Inc.’s stock is down 11.19%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Creative Medical Technology Holdings, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of May 02, 2025,, no analysts have changed their rating of Creative Medical Technology Holdings, Inc.’s stock over the last month.

Additionally, you'll want to evaluate Creative Medical Technology Holdings, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Creative Medical Technology Holdings, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Creative Medical Technology Holdings, Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Creative Medical Technology Holdings, Inc. (CELZ) by visiting AAII Stock Evaluator.

Relative Price Strength of Creative Medical Technology Holdings, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 02, 2025, Creative Medical Technology Holdings, Inc. has a weighted four-quarter relative price strength of -21.70%, which translates to a Momentum Score of 10 and is considered to be Very Weak.

Want to learn more about how Creative Medical Technology Holdings, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Creative Medical Technology Holdings, Inc. Stock Price: Bottom Line

As of May 5, 2025, Creative Medical Technology Holdings, Inc.’s stock price is $2.052, which is up 2.58% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Creative Medical Technology Holdings, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.